Dr. Newburger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Worcester, MA 01655Phone+1 774-441-8083Fax+1 774-441-8057
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1976 - 1979
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1974 - 1976
- Harvard Medical SchoolClass of 1974
Certifications & Licensure
- MA State Medical License 1978 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Editor in Chief Pediatric Blood and Cancer
- Regional Top Doctor Castle Connolly, 2014
- Elected Member The American Society for Clinical Investigation, 1986
- Join now to see all
Clinical Trials
- Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease Start of enrollment: 2015 Oct 29
- International Registry for Severe Chronic Neutropenia Start of enrollment: 1994 Jun 01
Roles: Contact
Publications & Presentations
PubMed
- Absence of Neutropenia in Patients With Early Exon Nonsense Mutations in ELANE : Clinical Evidence to Support Gene Therapy Approaches for Severe Congenital Neutropenia.Margret Joos, Timothy H Chang, Akiko Shimamura, Peter E Newburger
Journal of Pediatric Hematology/oncology. 2024-08-01 - 2 citationsClinical Remission of Severe Crohn's Disease with Empagliflozin Monotherapy in a Pediatric Patient with Glycogen Storage Disease Type 1b.Lauren V Collen, Peter E Newburger, Scott B Snapper
JPGN Reports. 2023-11-01 - Reply to: Stand with Ukraine.Peter E Newburger, Thomas G Gross
Pediatric Blood & Cancer. 2023-07-01
Abstracts/Posters
- Severe Chronic Neutropenia in the Large Granular Lymphocyte Syndrome: Outcomes in Response to Granulocyte Colony Stimulating Factor (G-CSF) and Immunosuppressive Thera...Peter E. Newburger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Myelodysplasia, Leukemia, Lymphoid Malignancies, and Other Cancers in Patients with Severe Chronic Neutropenia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Cancer Medicine and HematologyHarvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 9/29/2013
- Cancer Medicine and HematologyHarvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 9/29/2013
Press Mentions
- Technology Developed at UMass Medical School Vastly Improves CRISPR/Cas9 AccuracyNovember 18th, 2015
Grant Support
- HOX Cluster Intergenic Non-Coding RNAS In Myeloid Differentiation And FunctionNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2012
- Novel Approach To Oral Gene Therapy For Chronic Granulomatous DiseaseNational Institute Of Allergy And Infectious Diseases2009–2010
- Gene Expression In Mature NeutrophilsNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2010
- REG Of The Nadph Oxidase By Anti-Inflammatory AgentsFogarty International Center1999–2001
- Transcriptional Regulation In Stem CellsNational Heart, Lung, And Blood Institute1996–2000
- ID Family Regulation Of Stem Cell DevelopmentNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
- Leukocyte Glutathione Peroxidase ExpressionNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1998
- White Blood Cell Oxidase ExpressionNational Institute Of Allergy And Infectious Diseases1992–1996
- White Blood Cell Oxidase In Leukemia And Normal CellsNational Cancer Institute1985–1991
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: